NanoMosaic
Latest round
- Series A
Last raised
- Dec 2021
Total raised
- $41M
Investors
- 5
About NanoMosaic
Based in Massachusetts, US, and founded in 2018 by John Boyce, and Qimin Quan, NanoMosaic LLC develops MosaicNeedle™, a device that performs early illness detection, prognostic monitoring, and biomarker identification. As of December 2021, NanoMosaic LLC. NanoMosaic LLC provides MosaicNeedle™, a nanoneedle detection for proteomics and multi-omics applications. Nanoneedles’ features include single-molecule sensitivity, absolute quantitation, label-free detection, small sample size, ultra-high throughput, and high-multiplex for protein and nucleic acid interrogation. In addition, the company is also developing Tessie, early disease detection and prognosis platform to enable rapid end-user customized chips (DIY) with antibodies and/or aptamers, eliminating sample prep reactions when working from plasma, and others.
Who invested in NanoMosaic
5 investors across 1 round
See all investors in NanoMosaic
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 6, 2021
Amount
$41M
Investors
Questions about NanoMosaic
Who invested in NanoMosaic?
NanoMosaic has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NanoMosaic raised?
NanoMosaic has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NanoMosaic last raise money?
NanoMosaic's most recent round on record is a Series A, in Dec 2021.
What does NanoMosaic do?
Based in Massachusetts, US, and founded in 2018 by John Boyce, and Qimin Quan, NanoMosaic LLC develops MosaicNeedle™, a device that performs early illness detection, prognostic monitoring, and biomarker identification.
Where is NanoMosaic headquartered?
NanoMosaic is headquartered in Woburn, US.
Which VCs invest in companies like NanoMosaic?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at NanoMosaic's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like NanoMosaic? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.